BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 396075)

  • 1. Urinary prostaglandins and kallikrein in essential hypertension.
    Weber PC; Scherer B; Held E; Siess W; Stoffel H
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():259s-261s. PubMed ID: 396075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
    Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
    Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():247s-250s. PubMed ID: 396074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and tissue kallikrein-kinin systems during acute administration of frusemide in normotensive and hypertensive humans.
    Ohman KP; Karlberg BE
    Clin Sci (Lond); 1991 Sep; 81(3):305-11. PubMed ID: 1655330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic and endocrine responses of the kidney to frusemide in mild essential hypertension.
    Mackay IG; Nath K; Cumming AD; Muir AL; Watson ML
    Clin Sci (Lond); 1985 Feb; 68(2):159-64. PubMed ID: 3881208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
    Clin Exp Hypertens (1978); 1980; 2(3-4):693-708. PubMed ID: 7000466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin excretion after furosemide in normal and low-renin essential hypertension.
    Scherer B; Witzgall H; Weber PC
    Klin Wochenschr; 1984 Aug; 62(16):777-82. PubMed ID: 6384651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary kallikrein in normal renin essential hypertension.
    Lawton WJ; Fitz AE
    Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased urinary kallikrein excretion in young borderline hypertensive patients.
    Ando K; Fujita T
    Clin Exp Hypertens A; 1983; 5(6):903-18. PubMed ID: 6349868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of renal prostaglandins, kallikrein, vasopressin and aldosterone in essential hypertension.
    Favre L; Jornot L; Riondel A; Vallotton M
    Clin Exp Hypertens A; 1985-1986; 7(12):1663-79. PubMed ID: 3869481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotension-aldosterone system, urinary prostaglandins and kallikrein in pregnancy-induced hypertension: evidence for a dysregulation of the renin-angiotensin-prostacyclin loop.
    Fievet P; Gregoire I; Agnes E; Herve MA; Carayon A; Mimram A; Boulanger JC; Fournier A
    J Hypertens Suppl; 1986 Dec; 4(5):S88-91. PubMed ID: 3471917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary kallikrein activity is not altered in human essential hypertension.
    Simonetti BM; Pierucci A; Taggi F; Morabito S; Vastano S; Marchetti S; Putini RL; Stirati G; Cinotti GA
    Uremia Invest; 1985-1986; 9(2):189-93. PubMed ID: 3915922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between kallikrein and PRA after intravenous furosemide.
    Cinotti GA; Stirati G; Taggi F; Ronci R; Simonetti BM; Pierucci A
    J Endocrinol Invest; 1979; 2(2):147-50. PubMed ID: 489923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of orally administered glandular kallikrein on urinary kallikrein and prostaglandin excretion, plasma immunoreactive prostanoids and platelet aggregation in essential hypertension.
    Ogawa K; Ito T; Ban M; Mochizuki M; Satake T
    Klin Wochenschr; 1985 Apr; 63(7):332-6. PubMed ID: 3889484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal urinary kallikrein in normotensive and hypertensive rats during enhanced excretion of water and electrolytes.
    Croxatto HR; Albertini R; Arriagada R; Roblero J; Rojas M; Rosas R
    Clin Sci Mol Med Suppl; 1976 Dec; 3():259s-261s. PubMed ID: 1071623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.
    MacDonald TM; Craig K; Watson ML
    Br J Clin Pharmacol; 1989 Dec; 28(6):683-94. PubMed ID: 2532921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats.
    Johnston CI; Matthews PG; Dax E
    Clin Sci Mol Med Suppl; 1976 Dec; 3():283s-286s. PubMed ID: 1071628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of renal kallikrein and prostaglandin in the control of renin release.
    Suzuki S; Kobayashi M; Hashiba K
    Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.